Peptide vaccine formulation controls the duration of antigen presentation and magnitude of tumor-specific CD8+ T cell response

Despite remarkable progresses in vaccinology, therapeutic cancer vaccines have not achieved their full potential. We previously showed that an excessively long duration of antigen presentation critically reduced the quantity and quality of vaccination-induced T cell responses and subsequent anti-tum...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Immunol
Asıl Yazarlar: Khong, Hiep, Volmari, Annika, Sharma, Meenu, Dai, Zhimin, Imo, Chinonye S., Hailemichael, Yared, Singh, Manisha, Moore, Derek T., Xiao, Zhilan, Huang, Xue-fei, Horvath, Thomas D., Hawke, David H., Overwijk., Willem W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5940548/
https://ncbi.nlm.nih.gov/pubmed/29643190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1700467
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller